Literature DB >> 25165546

Invasive fungal infections in transplant recipients.

Jose A Vazquez1, Marisa H Miceli2, George Alangaden2.   

Abstract

Invasive fungal infections are an important cause of morbidity and mortality in hematopoietic stem cell transplant and solid organ transplant recipients. Evolving transplant modalities and techniques, complex and extensive immunosuppressant strategies, and the increased use of broad spectrum antifungal prophylaxis has greatly impacted the epidemiology and temporal pattern of invasive fungal infections in the transplant population. The goal of this article is to provide an up-to-date review of the most commonly encountered invasive fungal infections seen in transplant recipients, including epidemiology, risk factors, clinical features, diagnostic dilemmas, management and their overall influence on outcomes.

Entities:  

Keywords:  Aspergillus; Candida; Mucor; antifungal agents; transplant recipients

Year:  2013        PMID: 25165546      PMCID: PMC4040723          DOI: 10.1177/2049936113491936

Source DB:  PubMed          Journal:  Ther Adv Infect Dis        ISSN: 2049-9361


  96 in total

Review 1.  Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis.

Authors:  Monique A S H Mennink-Kersten; J Peter Donnelly; Paul E Verweij
Journal:  Lancet Infect Dis       Date:  2004-06       Impact factor: 25.071

Review 2.  Diagnosis of invasive fungal infections in hematology and oncology--guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO).

Authors:  M Ruhnke; A Böhme; D Buchheidt; O Cornely; K Donhuijsen; H Einsele; R Enzensberger; H Hebart; C P Heussel; M Horger; H Hof; M Karthaus; W Krüger; G Maschmeyer; O Penack; J Ritter; S Schwartz
Journal:  Ann Oncol       Date:  2011-09-23       Impact factor: 32.976

Review 3.  Non-culture-based diagnostics for opportunistic fungi.

Authors:  Monique A S H Mennink-Kersten; Paul E Verweij
Journal:  Infect Dis Clin North Am       Date:  2006-09       Impact factor: 5.982

4.  Echinocandins--first-choice or first-line therapy for invasive candidiasis?

Authors:  Jack D Sobel; Sanjay G Revankar
Journal:  N Engl J Med       Date:  2007-06-14       Impact factor: 91.245

Review 5.  Emerging moulds: epidemiological trends and antifungal resistance.

Authors:  Marisa H Miceli; Samuel A Lee
Journal:  Mycoses       Date:  2011-06-14       Impact factor: 4.377

6.  Disseminated infection by Scedosporium prolificans: an emerging fatality among haematology patients. Case report and review.

Authors:  J Maertens; K Lagrou; H Deweerdt; I Surmont; G E Verhoef; J Verhaegen; M A Boogaerts
Journal:  Ann Hematol       Date:  2000-06       Impact factor: 3.673

7.  Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Authors:  Alison G Freifeld; Eric J Bow; Kent A Sepkowitz; Michael J Boeckh; James I Ito; Craig A Mullen; Issam I Raad; Kenneth V Rolston; Jo-Anne H Young; John R Wingard
Journal:  Clin Infect Dis       Date:  2011-02-15       Impact factor: 9.079

8.  Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality.

Authors:  Matthew Morrell; Victoria J Fraser; Marin H Kollef
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

9.  A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

Authors:  Peter G Pappas; John H Rex; Jeannette Lee; Richard J Hamill; Robert A Larsen; William Powderly; Carol A Kauffman; Newton Hyslop; Julie E Mangino; Stanley Chapman; Harold W Horowitz; John E Edwards; William E Dismukes
Journal:  Clin Infect Dis       Date:  2003-08-14       Impact factor: 9.079

10.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

View more
  13 in total

Review 1.  Overcoming antifungal resistance.

Authors:  Anand Srinivasan; Jose L Lopez-Ribot; Anand K Ramasubramanian
Journal:  Drug Discov Today Technol       Date:  2014-03

2.  International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method.

Authors:  A Espinel-Ingroff; A L Colombo; S Cordoba; P J Dufresne; J Fuller; M Ghannoum; G M Gonzalez; J Guarro; S E Kidd; J F Meis; T M S C Melhem; T Pelaez; M A Pfaller; M W Szeszs; J P Takahaschi; A M Tortorano; N P Wiederhold; J Turnidge
Journal:  Antimicrob Agents Chemother       Date:  2015-12-07       Impact factor: 5.191

3.  Infections in Hematopoietic Cell Transplant Recipients: Results From the Organ Transplant Infection Project, a Multicenter, Prospective, Cohort Study.

Authors:  Mindy G Schuster; Angela A Cleveland; Erik R Dubberke; Carol A Kauffman; Robin K Avery; Shahid Husain; David L Paterson; Fernanda P Silveira; Tom M Chiller; Kaitlin Benedict; Kathleen Murphy; Peter G Pappas
Journal:  Open Forum Infect Dis       Date:  2017-03-22       Impact factor: 3.835

4.  Successful Treatment of Recurrent Pulmonary Mucormycosis in a Renal Transplant Patient: A Case Report and Literature Review.

Authors:  Morgan S Martin; Alison A Smith; Monica Lobo; Anil S Paramesh
Journal:  Case Rep Transplant       Date:  2017-03-13

Review 5.  Management of Antimicrobial Agents in Abdominal Organ Transplant Patients in Intensive Care Unit.

Authors:  Aaron Kaviani; Dilek Ince; David A Axelrod
Journal:  Curr Transplant Rep       Date:  2020-01-24

6.  Optimization of the antifungal metabolite production in Streptomyces libani isolated from northern forests soils in Iran.

Authors:  Maryam Azish; Masoomeh Shams Ghahfarokhi; Mehdi Razzaghi Abyaneh
Journal:  Curr Med Mycol       Date:  2020-12

7.  Elucidation of antimicrobial activity and mechanism of action by N-substituted carbazole derivatives.

Authors:  Johannes D Clausen; Lasse Kjellerup; Karen O'Hanlon Cohrt; John Bondo Hansen; William Dalby-Brown; Anne-Marie L Winther
Journal:  Bioorg Med Chem Lett       Date:  2017-09-01       Impact factor: 2.823

8.  Screening for Non-polyenic Antifungal Produced by Actinobacteria from Moroccan Habitats: Assessment of Antimycin A19 Production by Streptomyces albidoflavus AS25.

Authors:  Ahmed Nafis; Najoua Elhidar; Brahim Oubaha; Salah Eddine Samri; Timo Niedermeyer; Yedir Ouhdouch; Lahcen Hassani; Mustapha Barakate
Journal:  Int J Mol Cell Med       Date:  2018-06-03

9.  Efficacy and safety of micafungin for the treatment of patients with proven or probable invasive aspergillosis: A non-comparative, multicenter, phase IV, open-label study.

Authors:  Yu Ji; Yongping Song; Fang Zhou; Ting Liu; Ming Jiang; Xielan Zhao; Xiaojun Huang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

10.  A Comparison of Candida Detection in Sputum by the Conventional Culture and Fluorescent Polymerase Chain Reaction Methods.

Authors:  Xiaoqun Xu; Huoyang Lv; Fengwei Zhang; Houyong Zhu; Long Cai
Journal:  Med Sci Monit       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.